Compile Data Set for Download or QSAR
Report error Found 614 Enz. Inhib. hit(s) with all data for entry = 1430
TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322792(US10183944, Example 162 | 2-(4-(4-((2-(4-(cyanomet...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322792(US10183944, Example 162 | 2-(4-(4-((2-(4-(cyanomet...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322794(US10183944, Example 164 | 4-((4-(2-(1,4-diazepan-1...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322795(US10183944, Example 165 | 2-(azepan-1-yl)-4-((4-(3...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322788(US10183944, Example 158 | 6-(2-(4-((2-(azepan-1-yl...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322789(US10183944, Example 159 | 2-(azepan-1-yl)-4-((4-(2...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322791(US10183944, Example 161 | 2-(1-(4-((2-(cyclohexyl(...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322800(US10183944, Example 170 | 6-(4-((2-(cyclohexyl(met...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322802(US10183944, Example 172 | 2-(azepan-1-yl)-4-((4-(2...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322797(US10183944, Example 167 | 2-(azepan-1-yl)-4-((4-(2...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322810(US10183944, Example 180 | 2-(azepan-1-yl)-4-((4-(4...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322809(US10183944, Example 179 | 2-(azepan-1-yl)-4-((4-(3...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322810(US10183944, Example 180 | 2-(azepan-1-yl)-4-((4-(4...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322813(US10183944, Example 183 | 4-((4-(2-(4-hydroxypiper...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322812(US10183944, Example 182 | 2-(azepan-1-yl)-4-((6-(2...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322805(US10183944, Example 175 | 2-(azepan-1-yl)-4-((4-(4...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322805(US10183944, Example 175 | 2-(azepan-1-yl)-4-((4-(4...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322808(US10183944, Example 178 | 2-(1-(4-((4-(4-ethyl-3-o...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322809(US10183944, Example 179 | 2-(azepan-1-yl)-4-((4-(3...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322808(US10183944, Example 178 | 2-(1-(4-((4-(4-ethyl-3-o...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322819(2-(1-(4-((4-(4-hydroxypiperidin-1- yl)phenyl)amino...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322820(2-(azepan-1-yl)-4-((4-(4-(2- hydroxyethyl)piperazi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322821(2-(1-(4-((4-(4-(2-hydroxyethyl)piperazin- 1-yl)phe...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322820(2-(azepan-1-yl)-4-((4-(4-(2- hydroxyethyl)piperazi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322814(US10183944, Example 184 | 2-(azepan-1-yl)-4-((4-(2...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322815(US10183944, Example 185 | 2-(1-(4-((4-(2-(4-hydrox...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322814(US10183944, Example 184 | 2-(azepan-1-yl)-4-((4-(2...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322816(US10183944, Example 186 | 2-(azepan-1-yl)-4-((4-(4...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322817(US10183944, Example 187 | 2-(1-(4-((4-(4-ethylpipe...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322826(2-(1-(4-((4-(4-(2-hydroxyethyl)piperidin- 1-yl)phe...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322826(2-(1-(4-((4-(4-(2-hydroxyethyl)piperidin- 1-yl)phe...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322827(2-(1-(4-((4-(2-(4-ethylpiperazin-1- yl)ethyl)pheny...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322827(2-(1-(4-((4-(2-(4-ethylpiperazin-1- yl)ethyl)pheny...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322828(2-(azepan-1-yl)-4-((4-(2-(piperazin-1- yl)ethyl)ph...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322828(2-(azepan-1-yl)-4-((4-(2-(piperazin-1- yl)ethyl)ph...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322829(4-((4-(2-aminoethoxy)phenyl)amino)-2- (azepan-1-yl...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322829(4-((4-(2-aminoethoxy)phenyl)amino)-2- (azepan-1-yl...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322822(2-(azepan-1-yl)-4-((4-(piperazin-1-yl) phenyl)amin...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322821(2-(1-(4-((4-(4-(2-hydroxyethyl)piperazin- 1-yl)phe...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322823(2-(1-(5-oxo-4-((4-(piperazin-1-yl)phenyl) amino)-5...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322822(2-(azepan-1-yl)-4-((4-(piperazin-1-yl) phenyl)amin...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322823(2-(1-(5-oxo-4-((4-(piperazin-1-yl)phenyl) amino)-5...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322825(2-(azepan-1-yl)-4-((4-(4-(2-hydroxyethyl) piperidi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322825(2-(azepan-1-yl)-4-((4-(4-(2-hydroxyethyl) piperidi...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322837(2-(1-(4-((4-(4-(cyanomethyl)piperazin-1- yl)phenyl...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322836(2-(4-(4-((2-(azepan-1-yl)-5-oxo-5,6- dihydropyrimi...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322838(US10183944, Example 208 | 3-(4-(4-((2-(azepan-1-yl...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322837(2-(1-(4-((4-(4-(cyanomethyl)piperazin-1- yl)phenyl...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322830(2-(1-(4-((4-(2-aminoethoxy)phenyl) amino)-5-oxo-5,...)
Affinity DataIC50: 10nMAssay Description:2.5 μL of 10% DMSO or compound in 10% DMSO was added to the wells in a 96 well V-bottom plate. Optimized concentration of in-house Syk enzyme (d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Asana Biosciences

US Patent
LigandPNGBDBM322831(2-(azepan-1-yl)-4-((4-(2-(4- hydroxypiperidin-1-yl...)
Affinity DataIC50: 10nMAssay Description:Two μL of 10% DMSO in blank, substrate control and positive control wells and 2 μL of test compound in test wells was added. Thirteen μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2019
Entry Details
US Patent

Displayed 1 to 50 (of 614 total ) | Next | Last >>
Jump to: